Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001192482-12-000063)

Filing Details

Accession Number:: 0001192482-12-000063
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-07 16:06:58
Reporting Period:: 2012-02-28

Filing Date:: 2012-03-07
Accepted Time:: 2012-03-07 16:06:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
352998	Igi Laboratories Inc	IG	Biological Products, (No Disgnostic Substances) (2836)	010355758

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1358088	Nadya Lawrence	C/O Igi Laboratories 105 Lincoln Avenue Buena NJ 08310	Exec. Vp-Sales & Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-28	130	$0.65	16,058	No	4	M	Direct
Common Stock	Disposition	2012-02-28	130	$1.15	15,928	No	4	S	Direct
Common Stock	Acquisiton	2012-03-01	4,870	$0.65	20,798	No	4	M	Direct
Common Stock	Disposition	2012-03-01	4,870	$1.15	15,928	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-02-28	130	$0.00	130	$0.65
Common Stock	Stock Option (Right to Buy)	Disposition	2012-03-01	4,870	$0.00	4,870	$0.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
209,870		2012-05-23	No	4	M	Direct
205,000		2012-05-23	No	4	M	Direct

Footnotes

The options vested immediately upon the date of grant, May 23, 2002.